Sinopharm News and Activities

Sinopharm is one of the...

• Forbes Global 2000 (#749);
• Fortune 500 China (#34);
• Global Fortune 500 (#119);
• Hang Seng;
• Sasac Enterprises;
• TOB Iconic 10,000.

Sinopharm is a company listed under the stock ticker 1099 (CN).

View the org chart displaying its 21 main executives

Most searched biographies at Sinopharm

• Wanyong Lian, President
• Wen Deyong, Non-Executive Director
• Chen Yuqing, Non-Executive Director

Popular executive movements at Sinopharm

• Bingxiang Zhao, Chairman of the Board, has left the company  (posted on December 1 2025).

Create your alert
to follow the executive moves at Sinopharm.

Sinopharm has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Sinopharm

• 解码国药智造：一家央企的生命健康创新答卷-新华网
• 打破“双十定律” AI重塑新药研发-中新社上海
• 《自然》子刊刊发国药集团科技创新重要研究成果-新华网
• 国药集团进博会“购物车”再扩容，战略合作再深化-新华网
• 太极集团党委书记、董事长俞敏：将传统中医药与现代科技深度融合 打造国潮健康新范式｜2025，我说中国式现代化（8） - 原创 - 海外网
• 我国首款猴痘疫苗获批临床
• 深圳特区报数字报
• 国药医工打造行业生态圈 开启数智新篇章-中新社上海
• View more press releases Close

Social media about Sinopharm

• Sinopharm on Wikipedia, Google News & Yahoo Finance
• Sinopharm on LinkedIn, X (Twitter) & YouTube